ClinicalTrials.Veeva

Menu

Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation

U

University of Verona

Status

Enrolling

Conditions

Rehabilitation
Multiple Sclerosis
Motor Deficits
Cognitive Deficit

Treatments

Device: Cognitive rehabilitation: CG group
Device: Combined rehabilitation: CbG group
Device: Motor rehabilitation: MG group

Study type

Interventional

Funder types

Other

Identifiers

NCT06820125
4257CESC

Details and patient eligibility

About

The first aim of this project is to investigate the effects of different high-tech neurorehabilitation interventions (cognitive, motor, and combined cognitive-motor) on both cognitive and motor disability outcomes in people with multiple sclerosis (MS).

The second aim is to identify the cognitive and motor profiles of MS patients who benefit the most from either the combined cognitive-motor rehabilitation intervention or the isolated cognitive or motor treatments.

Enrollment

48 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • presence of mild (one or two neuropsychological tests below the cut-off score, 5th percentile) or severe (more than two neuropsychological tests below the cut-off score, 5th percentile) cognitive impairment,
  • mild to moderate walking disability with Expanded Disability Status Scale (EDSS) between 3 and 6,
  • no relapse or associated steroid use in the past three months,
  • adequate visual and auditory capacity to operate computer software.

Exclusion criteria

  • presence of other neurological disorders than MS,
  • major psychiatric disorders,
  • high levels of anxiety and/or depression (score>20 for Depression scale and up to 14 for Anxiety scale on Italian adaptation of the Depression, Anxiety and Stress Scale (DASS-21),
  • substance abuse,
  • any type of rehabilitation intervention in the month prior to recruitment
  • pharmacological therapy not well defined and/or changed during the study
  • presence of paroxysmal vertigo
  • lower limb botulinum toxin injections within the previous 12 weeks

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

48 participants in 3 patient groups

Cognitive Group (CG)
Experimental group
Description:
60 minutes of cognitive training with a computerized device
Treatment:
Device: Cognitive rehabilitation: CG group
Motor Group (MG)
Experimental group
Description:
60 minutes of robot-assisted gait training with the G-EO System
Treatment:
Device: Motor rehabilitation: MG group
Combined Group (CbG)
Experimental group
Description:
30 minutes of cognitive training with a computerized device + 30 minutes of robot-assisted gait training with the G-EO System.
Treatment:
Device: Combined rehabilitation: CbG group

Trial contacts and locations

1

Loading...

Central trial contact

Valentina Varalta

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems